National Research/NRC

$30.37

0.4%
-
1D1W1MYTD1YMAX

About National Research

National Research Corporation, doing business as NRC Health, is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare organizations in the United States. Its digital solutions consist of three primary solution categories: Marketing, Reputation and Experience. Its Marketing solutions are subscription-based services that allow for improved tracking of awareness, perception, and consistency of healthcare brands; real-time assessment of competitive differentiators, and enhanced segmentation tools to evaluate the needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. The Company's Experience solutions are provided on a subscription basis via a cross-continuum multi-mode digital platform. Its Reputation solutions allow healthcare organizations to share a picture of their organization.

Ticker

NRC

Sector

Industrials

Trading on

NASDAQ

Industry

Biotechnology & Drugs

CEO

Michael Hays

Employees

435

Headquarters

Lincoln, United States

NRC Metrics

BasicAdvanced
$744M
Market cap
25.13
P/E ratio
$1.24
EPS
0.59
Beta
$0.48
Dividend rate
1.54%
Dividend yield
$744M
0.58631
$47.25
$28.51
64K
$0.48
0.41
74.622
113.88
119.33%
132.55%
23.8%
54.41%
35.67%
25.126
5.045
20.132
1.25%
1.54%
1.54%
-1.46%
2.2%
3.69%
-4.65%
31.73%

NRC Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
17.84% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$35M
-7.11%
Net income
$6.3M
-28.41%
Profit margin
17.84%
-22.94%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for National Research stock?

National Research (NRC) has a market cap of $722M as of May 25, 2024.

What is the P/E ratio for National Research stock?

The price to earnings (P/E) ratio for National Research (NRC) stock is 24.4 as of May 25, 2024.

Does National Research stock pay dividends?

Yes, the National Research (NRC) stock pays dividends to shareholders. As of May 25, 2024, the dividend rate is $0.48 and the yield is 1.59%. National Research has a payout ratio of 119.33% on a trailing twelve-month basis.

When is the next National Research dividend payment date?

The next National Research (NRC) dividend payment is scheduled for July 15, 2024.

What is the beta indicator for National Research?

National Research (NRC) has a beta rating of 0.58. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the National Research stock price target?

The target price for National Research (NRC) stock is $, which is 100% below the current price of $30.34. This is an average based on projections from analyst, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell National Research stock

Buy or sell National Research stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing